1:13 - An overview of the latest analysis of TREMFYA
5:10 - Can you tell me a bit more about the study design of the NMA that was presented?
7:35 - You briefly touched on the findings of the NMA, can you go into some more detail about the precise findings?
10:52 - Were you surprised by the results of the study?
11:28 - What is the clinical significance of these results?
12:28 - Were there any strengths or limitations of the study that you'd like to highlight?
13:50 - Is there anything else you'd like rheumatologists to know before we wrap up?